Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Tumor Necrosis Factor’s Pathway in Crohn’s Disease: Potential for Intervention

International Journal of Molecular Sciences(2021)10.3390/ijms221910273Source: DataRank Database

Tumor Necrosis Factor’s Pathway in Crohn’s Disease: Potential for Intervention is a research paper published in International Journal of Molecular Sciences (2021). On theSindex it has a DataRank of 0. It has been cited 34 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access34 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: goldTopics (29)IDs (PubMed, PMC)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Fabio Cominelli ORCID,Cristiano Pagnini ORCID

Live enrichment

PubMed:34638616 PMC:PMC8508644

National Institutes of Health

Grant: 5P01DK091222-08

Innate Immunity and Experimental Crohn's Disease

National Institutes of Health

Grant: 5P30DK097948-05

The Cleveland Digestive Diseases Research Core Center (DDRCC)

National Institutes of Health

Grant: 2R01DK055812-04

Mechanisms of Experimental Crohns Disease

National Institutes of Health

Grant: 5R37DK042191-20

CYTOKINES AND INFLAMMATORY BOWEL DISEASE

goldLicense: CC BY

publisherhttps://www.mdpi.com/1422-0067/22/19/10273/pdf

Unpaywallhttps://www.mdpi.com/1422-0067/22/19/10273/pdf?version=1632470612

Europe_PMChttps://europepmc.org/articles/PMC8508644

Europe_PMChttps://europepmc.org/articles/PMC8508644?pdf=render

https://doi.org/10.3390/ijms221910273

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

HumansCrohn DiseaseTumor Necrosis Factor-alphaAnti-Inflammatory AgentsImmunosuppressive AgentsMolecular Targeted TherapyAdalimumabCertolizumab PegolInfliximabTumor Necrosis Factor Inhibitors

Keywords

Tumor necrosis factorinnate immunityInfliximabAnti-tnfAdalimumabCrohn’s DiseaseCertolizumabTumor Necrosis Factor-alphaAnti-Inflammatory AgentsReviewCrohn DiseaseCertolizumab PegolHumansTumor Necrosis Factor InhibitorsMolecular Targeted TherapyImmunosuppressive Agents

Sustainable Development Goals

SDG 3: 3. Good health

Tumor Necrosis Factor’s Pathway in Crohn’s Disease: Potential for Intervention

FAIR Checklist

Authors (2)

Funding (4 grants)

Open Access

Topics

Annotations (Europe PMC)